Infinity Investment Partners

Infinity Investment Partners is an independent investment firm established in 2019, focused on forging significant partnerships with highly sophisticated investors. The firm's core mission is to deliver unique insights and foster long-term value creation for its investors across both private and public markets. They employ a proven and structured approach, developed over two decades, to identify and allocate capital to promising ideas and themes on a global scale.

The firm leverages a deep network of relationships within alternative asset classes to generate superior returns for its partners. Infinity Investment Partners operates as a boutique asset manager, investing across a diverse range of opportunities including public, private, credit, and equity. Their investment strategy is broad, encompassing various sectors and aiming for global reach.

Notable investments by Infinity Investment Partners include companies such as Moa Technology, Eris Lifesciences, and Atom Bank, spanning industries like Biotechnology, Pharmaceuticals, and National Banks. They have also invested in companies within Banking Tech, Investment Tech, and Life Sciences Tech sectors, with a recent Series C round in Genomics. The firm primarily invests in companies from the United Kingdom and the United States.

The team at Infinity Investment Partners includes key individuals such as Michele Gesualdi, the founder, Giulia Silvestri, Director of Business Development and Investor Relations, and Fiona Allen, an Executive Director. The firm is authorized and regulated by the Financial Conduct Authority in the UK and Infinity Investment Management, a related entity, is authorized and regulated by the Central Bank of Ireland.